CARLI VAN HOY: Open Payments
NPI 1487279980 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 32 payments from 9 companies in 2025. Trend: 2023 $269 · 2024 $521 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 8 | $229 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $85 |
| Teleflex LLC | 3 | $84 |
| Amgen Inc. | 5 | $80 |
| PFIZER INC. | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Edwards Lifesciences Corporation | 1 | $28 |
| Chiesi USA, Inc. | 1 | $14 |
Products named: AMVUTTRA, LifeVest, REPATHA, LEQVIO, BRILINTA, ELIQUIS, ORSIRO MISSION, GUIDELINER.
Industry payments across IN — which companies pay providers there.
